Integrated bioinformatics analysis and experimental validation reveal the relationship between ALOX5AP and the prognosis and immune microenvironment in glioma
Abstract Background Treatment of gliomas, the most prevalent primary malignant neoplasm of the central nervous system, is challenging. Arachidonate 5-lipoxygenase activating protein (ALOX5AP) is crucial for converting arachidonic acid into leukotrienes and is associated with poor prognosis in multip...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMC
2024-08-01
|
| Sarja: | BMC Medical Genomics |
| Aiheet: | |
| Linkit: | https://doi.org/10.1186/s12920-024-01991-8 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|